315 related articles for article (PubMed ID: 34809715)
1. Sevoflurane preconditioning promotes mesenchymal stem cells to relieve myocardial ischemia/reperfusion injury via TRPC6-induced angiogenesis.
Yang J; Tang L; Zhang F; Yang T; Lu T; Sun K; Sun N; Ren J; Yan M
Stem Cell Res Ther; 2021 Nov; 12(1):584. PubMed ID: 34809715
[TBL] [Abstract][Full Text] [Related]
2. Preconditioning of mesenchymal stem cells by sevoflurane to improve their therapeutic potential.
Sun X; Fang B; Zhao X; Zhang G; Ma H
PLoS One; 2014; 9(3):e90667. PubMed ID: 24599264
[TBL] [Abstract][Full Text] [Related]
3. Preconditioning mesenchymal stem cells with transforming growth factor-alpha improves mesenchymal stem cell-mediated cardioprotection.
Herrmann JL; Wang Y; Abarbanell AM; Weil BR; Tan J; Meldrum DR
Shock; 2010 Jan; 33(1):24-30. PubMed ID: 19996917
[TBL] [Abstract][Full Text] [Related]
4. Effects of Sevoflurane Pretreatment on Myocardial Ischemia-Reperfusion Injury Through the Akt/Hypoxia-Inducible Factor 1-alpha (HIF-1α)/Vascular Endothelial Growth Factor (VEGF) Signaling Pathway.
Dong J; Xu M; Zhang W; Che X
Med Sci Monit; 2019 Apr; 25():3100-3107. PubMed ID: 31028241
[TBL] [Abstract][Full Text] [Related]
5. Myocardial transfection of hypoxia-inducible factor-1α and co-transplantation of mesenchymal stem cells enhance cardiac repair in rats with experimental myocardial infarction.
Huang B; Qian J; Ma J; Huang Z; Shen Y; Chen X; Sun A; Ge J; Chen H
Stem Cell Res Ther; 2014 Feb; 5(1):22. PubMed ID: 24507665
[TBL] [Abstract][Full Text] [Related]
6. Sevoflurane preconditioning alleviates myocardial ischemia reperfusion injury through mitochondrial NAD
Qin X; Qin Q; Ran K; Yuan G; Chang Y; Wang Y; Xiao Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Aug; 47(8):1108-1119. PubMed ID: 36097779
[TBL] [Abstract][Full Text] [Related]
7. Preconditioning of umbilical cord-derived mesenchymal stem cells by rapamycin increases cell migration and ameliorates liver ischaemia/reperfusion injury in mice via the CXCR4/CXCL12 axis.
Zheng J; Li H; He L; Huang Y; Cai J; Chen L; Zhou C; Fu H; Lu T; Zhang Y; Yao J; Yang Y
Cell Prolif; 2019 Mar; 52(2):e12546. PubMed ID: 30537044
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia pretreatment improves the therapeutic potential of bone marrow mesenchymal stem cells in hindlimb ischemia via upregulation of NRG-1.
Peng X; Liang B; Wang H; Hou J; Yuan Q
Cell Tissue Res; 2022 Apr; 388(1):105-116. PubMed ID: 35091805
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia-preconditioned mesenchymal stem cells prevent renal fibrosis and inflammation in ischemia-reperfusion rats.
Ishiuchi N; Nakashima A; Doi S; Yoshida K; Maeda S; Kanai R; Yamada Y; Ike T; Doi T; Kato Y; Masaki T
Stem Cell Res Ther; 2020 Mar; 11(1):130. PubMed ID: 32197638
[TBL] [Abstract][Full Text] [Related]
10. Modulation of p75
Elshaer SL; Park HS; Pearson L; Hill WD; Longo FM; El-Remessy AB
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33467640
[TBL] [Abstract][Full Text] [Related]
11. LncRNA SNHG1 alleviates hypoxia-reoxygenation-induced vascular endothelial cell injury as a competing endogenous RNA through the HIF-1α/VEGF signal pathway.
Liang S; Ren K; Li B; Li F; Liang Z; Hu J; Xu B; Zhang A
Mol Cell Biochem; 2020 Feb; 465(1-2):1-11. PubMed ID: 31792649
[TBL] [Abstract][Full Text] [Related]
12. Preconditioning of mesenchymal stem cells with ghrelin exerts superior cardioprotection in aged heart through boosting mitochondrial function and autophagy flux.
Sun L; Zhang W
Eur J Pharmacol; 2021 Jul; 903():174142. PubMed ID: 33951411
[TBL] [Abstract][Full Text] [Related]
13. Hypoxia pretreatment of bone marrow mesenchymal stem cells facilitates angiogenesis by improving the function of endothelial cells in diabetic rats with lower ischemia.
Liu J; Hao H; Xia L; Ti D; Huang H; Dong L; Tong C; Hou Q; Zhao Y; Liu H; Fu X; Han W
PLoS One; 2015; 10(5):e0126715. PubMed ID: 25996677
[TBL] [Abstract][Full Text] [Related]
14. Lipopolysaccharide preconditioning enhances the efficacy of mesenchymal stem cells transplantation in a rat model of acute myocardial infarction.
Yao Y; Zhang F; Wang L; Zhang G; Wang Z; Chen J; Gao X
J Biomed Sci; 2009 Aug; 16(1):74. PubMed ID: 19691857
[TBL] [Abstract][Full Text] [Related]
15. Hypoxic preconditioning improves the survival and neural effects of transplanted mesenchymal stem cells via CXCL12/CXCR4 signalling in a rat model of cerebral infarction.
Hu Y; Chen W; Wu L; Jiang L; Qin H; Tang N
Cell Biochem Funct; 2019 Oct; 37(7):504-515. PubMed ID: 31368195
[TBL] [Abstract][Full Text] [Related]
16. Mesenchymal stem cells preconditioned with trimetazidine promote neovascularization of hearts under hypoxia/reoxygenation injury.
Hu X; Yang J; Wang Y; Zhang Y; Ii M; Shen Z; Hui J
Int J Clin Exp Med; 2015; 8(9):16991-7005. PubMed ID: 26629255
[TBL] [Abstract][Full Text] [Related]
17. VEGF is critical for stem cell-mediated cardioprotection and a crucial paracrine factor for defining the age threshold in adult and neonatal stem cell function.
Markel TA; Wang Y; Herrmann JL; Crisostomo PR; Wang M; Novotny NM; Herring CM; Tan J; Lahm T; Meldrum DR
Am J Physiol Heart Circ Physiol; 2008 Dec; 295(6):H2308-14. PubMed ID: 18849336
[TBL] [Abstract][Full Text] [Related]
18. Cellular repressor of E1A-stimulated gene overexpression in bone mesenchymal stem cells protects against rat myocardial infarction.
Peng C; Pei H; Wei F; Tian X; Deng J; Yan C; Li Y; Sun M; Zhang J; Liu D; Rong J; Wang J; Gao E; Li S; Han Y
Int J Cardiol; 2015 Mar; 183():232-41. PubMed ID: 25679992
[TBL] [Abstract][Full Text] [Related]
19. Intravenous Anesthetics Enhance the Ability of Human Bone Marrow-Derived Mesenchymal Stem Cells to Alleviate Hepatic Ischemia-Reperfusion Injury in a Receptor-Dependent Manner.
Feng J; Yao W; Zhang Y; Xiang AP; Yuan D; Hei Z
Cell Physiol Biochem; 2018; 47(2):556-566. PubMed ID: 29794450
[TBL] [Abstract][Full Text] [Related]
20. Bone marrow-derived mesenchymal stem cells induced by inflammatory cytokines produce angiogenetic factors and promote prostate cancer growth.
Yang KQ; Liu Y; Huang QH; Mo N; Zhang QY; Meng QG; Cheng JW
BMC Cancer; 2017 Dec; 17(1):878. PubMed ID: 29268703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
